Markets /MEDXF Medexus Pharmaceuticals Inc. MEDXF Full chart Compare Add to watchlist Set alert Price alert · MEDXF Alert when the price is Price abovePrice below Price level Set alert All alert types 3.56 USD +0.14 (+4.10%) At close·Nov 3, 2026, 4:00 PM EST 3.48 Day range 3.50 1.80 52-week range 3.96 YTD +68.48%1 year +76.87% Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2026FY 2025FY 2024FY 2023 Revenue → Gross Profit: $54.41MGross Profit → Expenses: $54.41MRevenue → Cost of Revenue: $44.92MExpenses → Selling, General & Admin: $39.42MExpenses → Research & Development: $8.87MExpenses → Other Operating Expenses: $287.00KExpenses → Interest Expense: $5.20MExpenses → Other Expenses: $2.91MExpenses → Income Tax: $120.00KNet Loss → Expenses: $2.39MGross Profit$54.41MNet Loss$2.39MCost of Revenue$44.92MExpenses$56.80MSelling, General & Admin$39.42MResearch & Development$8.87MOther Operating Expenses$287.00KInterest Expense$5.20MOther Expenses$2.91MIncome Tax$120.00KRevenue$99.33M No annual statement lines MEDXF has no annual lines for this statement.
